Relapsing Polychondritis
📧 Sign up to get email alerts when something new happens for Relapsing Polychondritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis
NIAMS sponsors a clinical trial to study the natural history, pathogenesis, and outcomes of idiopathic systemic vasculitis, with recruiting …
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: An Open-Label Study of Effectiveness of Immunomodulatory Medications for Patients With Relapsing Polychondritis [Phase 2]
Phase 2 open-label clinical trial evaluating immunomodulatory medications for Relapsing Polychondritis; currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Longitudinal Study for Relapsing Polychondritis
A longitudinal clinical trial for Relapsing Polychondritis sponsored by the University of Pennsylvania is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-06-17Clinical Trial Update: Biologics in Refractory Vasculitis: A Trial of Biologic Therapy for Refractory Primary Non-ANCA Associated Vasculitis [Phase 2]
This update reports results from a Phase 2 trial of a biologic therapy for refractory primary non-ANCA associated vasculitis; the study was …
-
CLINICAL_TRIALS research · 2025-03-12Clinical Trial Update: Efficacy, Safety and Immunological Evaluation of Upadacitinib for Relapsing Polychondritis [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating Upadacitinib for Relapsing Polychondritis, with efficacy, safety and immunological assessments, and…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-02-26Clinical Trial Update: Low-dose Recombinant Human IL-2 for the Treatment of Relapsing Polychondritis [Phase 2]
Phase 2 clinical trial update evaluating low-dose recombinant human IL-2 for relapsing polychondritis has completed.
-
CLINICAL_TRIALS trial_result · 2021-03-03Clinical Trial Update: Single Patient Study to Treat Relapsing Polychondritis With Tocilizumab [NA]
A single-patient study evaluating tocilizumab for relapsing polychondritis has completed; results posted in 2021.
-
CLINICAL_TRIALS withdrawal · 2014-05-13Clinical Trial Update: Tocilizumab for Relapsing Polychondritis [Phase 2]
A Phase 2 clinical trial evaluating tocilizumab for Relapsing Polychondritis has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2012-08-07Clinical Trial Update: Study on the Safety of Abatacept in Relapsing Polychondritis [Phase 1]
Phase 1 study assessing the safety of abatacept in relapsing polychondritis has completed.